Accelerated transformation of macrophage-derived foam cells in the presence of collagen-induced arthritis mice serum is associated with dyslipidemia

References

• Tyrrell, P. N., J. Beyene, B. M. Feldman, et al. 2010. Rheumatic disease and carotid intima-media thickness: a systematic review and meta-analysis. Arterioscler. Thromb. Vasc. Biol. 30: 1014–1026
   PubMed Web of Science ®Google Scholar
• Avina-Zubieta, J. A., J. Thomas, M. Sadatsafavi, et al. 2012. Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. Ann. Rheum. Dis. 71: 1524–1529
   PubMed Web of Science ®Google Scholar
• Maradit-Kremers, H., C. S. Crowson, P. J. Nicola, et al. 2005. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis. Rheum. 52: 402–411
   PubMed Web of Science ®Google Scholar
• Maradit-Kremers, H., P. J. Nicola, C. S. Crowson, et al. 2005. Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis. Rheum. 52: 722–732
   PubMed Web of Science ®Google Scholar
• Watson, D. J., T. Rhodes, and H. A. Guess. 2003. All-cause mortality and vascular events among patients with rheumatoid arthritis, osteoarthritis, or no arthritis in the UK General Practice Research Database. J. Rheumatol. 30: 1196–1202
   PubMed Web of Science ®Google Scholar
• Chung, C. P., A. Oeser, P. Raggi, et al. 2005. Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors. Arthritis. Rheum. 52: 3045–3053
   PubMed Web of Science ®Google Scholar
• Shoenfeld, Y., R. Gerli, A. Doria, et al. 2005. Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation 112: 3337–3347
   PubMed Web of Science ®Google Scholar
• Pasceri, V., and E. T. Yeh. 1999. A tale of two diseases: atherosclerosis and rheumatoid arthritis. Circulation 100: 2124–2126
   PubMed Web of Science ®Google Scholar
• Libby, P. 2008. Role of inflammation in atherosclerosis associated with rheumatoid arthritis. Am. J. Med. 121: S21–S31
   PubMed Web of Science ®Google Scholar
• Montecucco, F., and F. Mach. 2009. Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis. Rheumatology (Oxford) 48: 11–22
   PubMed Web of Science ®Google Scholar
• Hahn, B. H., J. Grossman, B. J. Ansell, et al. 2008. Altered lipoprotein metabolism in chronic inflammatory states: proinflammatory high-density lipoprotein and accelerated atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis. Arthritis. Res. Ther. 10: 213
   PubMed Web of Science ®Google Scholar
• He, M., X. Liang, L. He, et al. 2013. Endothelial dysfunction in rheumatoid arthritis: the role of monocyte chemotactic protein-1-induced protein. Arterioscler. Thromb. Vasc. Biol. 33: 1384–1391
   PubMed Web of Science ®Google Scholar
• Ross, R. 1999. Atherosclerosis is an inflammatory disease. Am. Heart J. 138: S419–S420
   PubMed Web of Science ®Google Scholar
• Nicholson, A. C., S. Frieda, A. Pearce, and R. L. Silverstein. 1995. Oxidized LDL binds to CD36 on human monocyte-derived macrophages and transfected cell lines. Evidence implicating the lipid moiety of the lipoprotein as the binding site. Arterioscler. Thromb. Vasc. Biol. 15: 269–275
   PubMed Web of Science ®Google Scholar
• Collot-Teixeira, S., J. Martin, C. McDermott-Roe, et al. 2007. CD36 and macrophages in atherosclerosis. Cardiovasc. Res. 75: 468–477
   PubMed Web of Science ®Google Scholar
• Pennings, M., I. Meurs, D. Ye, et al. 2006. Regulation of cholesterol homeostasis in macrophages and consequences for atherosclerotic lesion development. Febs. Lett. 580: 5588–5596
   PubMed Web of Science ®Google Scholar
• Oram, J. F., and J. W. Heinecke. 2005. ATP-binding cassette transporter A1: a cell cholesterol exporter that protects against cardiovascular disease. Physiol. Rev. 85: 1343–1372
   PubMed Web of Science ®Google Scholar
• Kennedy, M. A., G. C. Barrera, K. Nakamura, et al. 2005. ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation. Cell Metab. 1: 121–131
   PubMed Web of Science ®Google Scholar
• Wang, J., B. Hu, L. Kong, et al. 2008. Native, oxidized lipoprotein(a) and lipoprotein(a) immune complex in patients with active and inactive rheumatoid arthritis: plasma concentrations and relationship to inflammation. Clin. Chim. Acta 390: 67–71
   PubMed Web of Science ®Google Scholar
• Myasoedova, E., C. S. Crowson, H. M. Kremers, et al. 2011. Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease. Ann. Rheum. Dis. 70: 482–487
   PubMed Web of Science ®Google Scholar
• Solomon, D. H., N. J. Goodson, J. N. Katz, et al. 2006. Patterns of cardiovascular risk in rheumatoid arthritis. Ann. Rheum. Dis. 65: 1608–1612
   PubMed Web of Science ®Google Scholar
• van Halm, V. P., M. M. Nielen, M. T. Nurmohamed, et al. 2007. Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis. Ann. Rheum. Dis. 66:184–188
   PubMed Web of Science ®Google Scholar
• Lee, Y. H., S. J. Choi, J. D. Ji, et al. 2000. Lipoprotein(a) and lipids in relation to inflammation in rheumatoid arthritis. Clin. Rheumatol. 19: 324–325
   PubMed Web of Science ®Google Scholar
• Steinberg, D. 2002. Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime. Nat. Med. 8: 1211–1217
   PubMed Web of Science ®Google Scholar
• Kim, S. H., C. K. Lee, E. Y. Lee, et al. 2004. Serum oxidized low-density lipoproteins in rheumatoid arthritis. Rheumatol. Int. 24: 230–233
   PubMed Web of Science ®Google Scholar
• Nozaki, S., H. Kashiwagi, S. Yamashita, et al. 1995. Reduced uptake of oxidized low density lipoproteins in monocyte-derived macrophages from CD36-deficient subjects. J. Clin. Invest. 96: 1859–1865
   PubMed Web of Science ®Google Scholar
• Moore, K. J., and M. W. Freeman. 2006. Scavenger receptors in atherosclerosis: beyond lipid uptake. Arterioscler. Thromb. Vasc. Biol. 26: 1702–1711
   PubMed Web of Science ®Google Scholar
• Febbraio, M., E. Guy, and R. L. Silverstein. 2004. Stem cell transplantation reveals that absence of macrophage CD36 is protective against atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 24: 2333–2338
   PubMed Web of Science ®Google Scholar
• Yu, X. H., Y. C. Fu, D. W. Zhang, et al. 2013. Foam cells in atherosclerosis. Clin. Chim. Acta 424: 245–252
   PubMed Web of Science ®Google Scholar
• Reiss, A. B., D. W. Wan, K. Anwar, et al. 2009. Enhanced CD36 scavenger receptor expression in THP-1 human monocytes in the presence of lupus plasma: linking autoimmunity and atherosclerosis. Exp. Biol. Med. (Maywood) 234: 354–360
   PubMed Web of Science ®Google Scholar
• Pennings, M., I. Meurs, D. Ye, et al. 2006. Regulation of cholesterol homeostasis in macrophages and consequences for atherosclerotic lesion development. Febs. Lett. 580: 5588–5596
   PubMed Web of Science ®Google Scholar
• Moore, K. J., E. D. Rosen, M. L. Fitzgerald, et al. 2001. The role of PPAR-gamma in macrophage differentiation and cholesterol uptake. Nat. Med. 7: 41–47
   PubMed Web of Science ®Google Scholar
• Han, S., and N. Sidell. 2002. Peroxisome-proliferator-activated-receptor gamma (PPARgamma) independent induction of CD36 in THP-1 monocytes by retinoic acid. Immunology 106: 53–59
   PubMed Web of Science ®Google Scholar
• Kashyap, S. R., A. G. Ioachimescu, H. L. Gornik, et al. 2009. Lipid-induced insulin resistance is associated with increased monocyte expression of scavenger receptor CD36 and internalization of oxidized LDL. Obesity (Silver Spring) 17: 2142–2148
   PubMed Web of Science ®Google Scholar
• Han, J., D. P. Hajjar, X. Zhou, et al. 2002. Regulation of peroxisome proliferator-activated receptor-gamma-mediated gene expression. A new mechanism of action for high density lipoprotein. J. Biol. Chem. 277: 23582–23586
   PubMed Web of Science ®Google Scholar
• McCarey, D. W., I. B. McInnes, R. Madhok, et al. 2004. Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial. Lancet 363: 2015–2021
   PubMed Web of Science ®Google Scholar
• Semb, A. G., I. Holme, T. K. Kvien, and T. R. Pedersen. 2011. Intensive lipid lowering in patients with rheumatoid arthritis and previous myocardial infarction: an explorative analysis from the incremental decrease in endpoints through aggressive lipid lowering (IDEAL) trial. Rheumatology (Oxford) 50: 324–329
   PubMed Web of Science ®Google Scholar
• Sheng, X., M. J. Murphy, T. M. Macdonald, and L. Wei. 2012. Effectiveness of statins on total cholesterol and cardiovascular disease and all-cause mortality in osteoarthritis and rheumatoid arthritis. J. Rheumatol. 39: 32–40
   PubMed Web of Science ®Google Scholar
• Inami, S., K. Okamatsu, M. Takano, et al. 2004. Effects of statins on circulating oxidized low-density lipoprotein in patients with hypercholesterolemia. Jpn. Heart J. 45: 969–975
   PubMedGoogle Scholar
• Homma, Y., I. Michishita, H. Hayashi, and H. Shigematsu. 2010. Effects of low-dose simvastatin on the distribution of plasma cholesterol and oxidized low-density lipoprotein in three ultra-centrifugally separated low-density lipoprotein subfractions: 12-month, open-label trial. J. Atheroscler. Thromb. 17: 1049–1053
   PubMed Web of Science ®Google Scholar